Joseph W. Dziedzic is the President and Chief Executive Officer of Integer Holdings Corporation, a leading medical device outsource manufacturer. With a robust background in the healthcare industry, Dziedzic has been instrumental in steering the company towards growth and innovation. He joined Integer Holdings in 2013 as the Senior Vice President of Quality and Regulatory Affairs, and his strategic vision and leadership quickly propelled him to the role of CEO in 2016. Prior to Integer, Dziedzic held various leadership positions at Boston Scientific Corporation, where he honed his expertise in medical device development and regulatory compliance. Under Dziedzic's leadership, Integer Holdings has expanded its global footprint and enhanced its product offerings, particularly in the cardiovascular and neuromodulation markets. His focus on operational excellence and customer-centric strategies has resulted in significant revenue growth and improved market share for the company. Dziedzic's commitment to fostering a culture of innovation is evident in the company's increased investment in research and development, which has led to the introduction of advanced medical technologies that meet the evolving needs of healthcare providers and patients worldwide. As CEO, Joseph W. Dziedzic continues to drive Integer Holdings forward by emphasizing sustainable growth and long-term value creation for stakeholders. His leadership style emphasizes collaboration and empowerment, enabling the company to attract top talent and maintain a competitive edge in the dynamic medical device industry. Dziedzic's strategic initiatives and dedication to excellence have solidified Integer Holdings' position as a trusted partner in the global healthcare sector.